The DOI matches its Crossref record; 148 of the 151 references it cites were found in a registry or an index.
Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties
Abstract
Steroids influence neuronal function through binding to cognate intracellular receptors which may act as transcription factors in the regulation of gene expression. In addition, certain so-called neuroactive steroids modulate ligand-gated ion channels via non-genomic mechanisms. Especially distinct 3alpha-reduced metabolites of progesterone and deoxycorticosterone are potent positive allosteric modulators of gamma-aminobutyric acid type A (GABA(A)) receptors. However, also classical steroid hormones such as 17beta-estradiol, testosterone and progesterone are neuroactive steroids because they may act as functional antagonists at the 5-hydroxytryptamine type 3 (5-HT(3)) receptor, a ligand-gated ion channel or distinct glutamate receptors. A structure-activity relationship for the actions of a variety of steroids at the 5-HT(3) receptor was elaborated that differed considerably from that known for GABA(A) receptors. Although a bindings site for steroids at GABA(A) receptors is still a matter of debate, meanwhile there is also evidence that steroids interact allosterically with ligand-gated ion channels at the receptor membrane interface. On the other hand, also 3alpha-reduced neuroactive steroids may regulate gene expression via the progesterone receptor after intracellular oxidation into 5alpha-pregnane steroids. Animal studies showed that progesterone is converted rapidly into GABAergic neuroactive steroids in vivo. Progesterone reduces locomotor activity in a dose-dependent fashion in male Wistar rats. Moreover, progesterone and 3alpha-reduced neuroactive steroids produce a benzodiazepine-like sleep EEG profile in rats and humans. During major depression, there is a disequilibrium of such 3alpha-reduced neuroactive steroids which is corrected by successful treatment with antidepressant drugs. Neuroactive steroids may further be involved in the treatment of depression and anxiety with antidepressants in patients during ethanol withdrawal. Studies in patients with panic disorder suggest that neuroactive steroids may also play a role in modulating human anxiety. Both the genomic and non-genomic effects of steroids in the brain may contribute to the pathophysiology of psychiatric disorders and the mechanisms of action of antidepressants. Neuroactive steroids affect a broad spectrum of behavioral functions through their unique molecular properties and may represent a new treatment strategy for neuropsychiatric disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
1 retracted
Dehydroepiandrosterone (DHEA) supplementation for cognitive function.
Huppert, F., & Van Niekerk, J. (2001) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000304 · Cited by 88
RetractedThe Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,394
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225
An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway
Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterström, R. H., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80900-9 · Cited by 1,534
Paul, S. M., & Purdy, R. H. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.6.1347506 · Cited by 1,413
Primary Structure And Functional Expression of the 5HT 3 Receptor, A Serotonin-gated Ion Channel
Maricq, A. V., Peterson, A. S., Brake, A. J., Myers, R., & Julius, D. J. (1991) · Science · doi:10.1126/science.1718042 · Cited by 978
St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor
Moore, L. B., Goodwin, B. J., Jones, S. A., Wisely, G. B., Serabjit‐Singh, C. J., Willson, T. M., Collins, J. L., & Kliewer, S. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130155097 · Cited by 946
Neurosteroids: biosynthesis and function of these novel neuromodulators
Compagnone, N. A., & Mellon, S. H. (2000) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0188 · Cited by 820
Neurosteroids and GABAA receptor function
Lambert, J. J., Belelli, D., Hill-Venning, C., & Peters, J. A. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89058-6 · Cited by 746
Steroid Hormone Receptors: Interaction with Deoxyribonucleic Acid and Transcription Factors*
Truss, M., & Beato, M. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-4-459 · Cited by 739
Research works printed but not linked: 3
- Carter, 1997, Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3α-hydroxy-3-methyl-5α-pregnan-20-one), a selective high-affinity steroid modulator of the GABAA receptor, J. Pharmacol. Exp. Ther., 280, 1284
- Monteleone, 2000, Allopregnanlone concentrations and premenstrual syndrome, Eur, J. Endocrinol., 142, 269
- Ströhle, A., Romeo, E., di Michele, F., Pasini, A., Hermann, B., Gajewski, G., Holsboer, F., Rupprecht, R. Induced panic attacks shift GABAA receptor modulatory steroid composition in patients with panic disorder: preliminary results. Arch. Gen. Psychiatry, in press.
Cited by
Sorted by citations
Neurosteroids: endogenous regulators of the GABAA receptor
Belelli, D., & Lambert, J. J. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1703 · Cited by 1,159
Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3295 · Cited by 930
Self-citationManinger, N., Wolkowitz, O. M., Reus, V. I., Epel, E. S., & Mellon, S. H. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.11.002 · Cited by 769
Role of GABA in anxiety and depression
Kalueff, A. V., & Nutt, D. (2006) · Depression and Anxiety · doi:10.1002/da.20262 · Cited by 563
Sex differences in anxiety and depression: Role of testosterone
McHenry, J. A., Carrier, N., Hull, E. M., & Kabbaj, M. (2013) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.09.001 · Cited by 526
Microbial steroid transformations: current state and prospects
Donova, M. V., & Egorova, O. V. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-012-4078-0 · Cited by 504
Anxiety disorders and GABA neurotransmission: a disturbance of modulation
Gauthier, I., & Nuss, P. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s58841 · Cited by 522
Neurosteroid modulation of GABAA receptors
Lambert, J. J., Belelli, D., Peden, D. R., Vardy, A., & Peters, J. A. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.09.001 · Cited by 498
Schumacher, M., Mattern, C., Ghoumari, A. M., Oudinet, J., Lière, P., Labombarda, F., Sitruk-Ware, R. L., Nicola, A. F. D., & Guennoun, R. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.09.004 · Cited by 368
Bandelow, B., Baldwin, D., Abelli, M., Bolea-Alamanac, B., Bourin, M., Chamberlain, S. R., Cinosi, E., Davies, S., Domschke, K., Fineberg, N., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1190867 · Cited by 347
The role of allopregnanolone in depression and anxiety
Schüle, C., Nothdurfter, C., & Rupprecht, R. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.09.003 · Cited by 333
Self-citationDepression gets old fast: do stress and depression accelerate cell aging?
Wolkowitz, O. M., Epel, E. S., Reus, V. I., & Mellon, S. H. (2010) · Depression and Anxiety · doi:10.1002/da.20686 · Cited by 298
Decreased Cerebrospinal Fluid Allopregnanolone Levels in Women with Posttraumatic Stress Disorder
Rasmusson, A. M., Pinna, G., Paliwal, P., Weisman, D., Gottschalk, C. H., Charney, D. S., Krystal, J. H., & Guidotti, A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.026 · Cited by 287
Zheng, P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.07.001 · Cited by 268
Steroids, neuroactive steroids and neurosteroids in psychopathology
Dubrovsky, B. O. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.001 · Cited by 250
Carver, C. M., & Reddy, D. S. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3276-5 · Cited by 257
Pinna, G., Costa, E., & Guidotti, A. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0213-2 · Cited by 245
Topical Review: Fetal Testosterone and Sex Differences in Typical Social Development and in Autism
Knickmeyer, R. C., & Baron-Cohen, S. (2006) · Journal of Child Neurology · doi:10.1177/08830738060210101601 · Cited by 230
Of sound mind and body: depression, disease, and accelerated aging
Wolkowitz, O. M., Reus, V. I., & Mellon, S. H. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/owolkowitz · Cited by 214
Neurosteroid regulation of central nervous system development
Mellon, S. H. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.04.011 · Cited by 209
Progesterone: the forgotten hormone in men?
Oettel, M., & Mukhopadhyay, A. (2004) · The Aging Male · doi:10.1080/13685530400004199 · Cited by 209
Neurosteroid modulation of synaptic and extrasynaptic GABAA receptors
Herd, M. B., Belelli, D., & Lambert, J. J. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.007 · Cited by 206
Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder
Rapkin, A. J., & Akopians, A. L. (2012) · Menopause international · doi:10.1258/mi.2012.012014 · Cited by 205
Emotion recognition accuracy in healthy young females is associated with cycle phase
Derntl, B., Kryspin‐Exner, I., Fernbach, E., Moser, E., & Habel, U. (2007) · Hormones and Behavior · doi:10.1016/j.yhbeh.2007.09.006 · Cited by 202
Neurosteroids and GABA-A Receptor Function
Wang, M. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00044 · Cited by 207
Steroids and glial cell function
García‐Segura, L. M., & Melcangi, R. C. (2006) · Glia · doi:10.1002/glia.20404 · Cited by 204
Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways
Taylor, C., Fricker, A. D., Devi, L. A., & Gomes, I. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2004.12.007 · Cited by 186
Neurosteroids: Endogenous allosteric modulators of GABAA receptors
Lambert, J. J., Cooper, M. A., Simmons, R. D. J., Weir, C. J., & Belelli, D. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.08.009 · Cited by 180
Wolkowitz, O. M., Burke, H., Epel, E. S., & Reus, V. I. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04980.x · Cited by 187
Edinger, K. L., & Frye, C. A. (2004) · Behavioral Neuroscience · doi:10.1037/0735-7044.118.6.1352 · Cited by 175
Porcu, P., Barron, A. M., Frye, C. A., Walf, A. A., Yang, S., He, X., Morrow, A. L., Panzica, G., & Melcangi, R. C. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12351 · Cited by 186
Reed, S. C., Levin, F. R., & Evans, S. M. (2008) · Hormones and Behavior · doi:10.1016/j.yhbeh.2008.02.018 · Cited by 170
Matsumoto, K., Pinna, G., Puia, G., Guidotti, A., & Costa, E. (2005) · Stress · doi:10.1080/10253890500159022 · Cited by 162
Exaggerated 5-HT1A but Normal 5-HT2A Receptor Activity in Individuals Ill with Anorexia Nervosa
Bailer, U. F., Frank, G. K., Henry, S. E., Price, J. C., Meltzer, C. C., Mathis, C. A., Wagner, A., Thornton, L., Hoge, J., Ziolko, S. K., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.018 · Cited by 161
Belelli, D., Herd, M. B., Mitchell, E. A., Peden, D. R., Vardy, A., Gentet, L. J., & Lambert, J. J. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.021 · Cited by 160
Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development
Frieder, A., Fersh, M., Hainline, R., & Deligiannidis, K. M. (2019) · CNS Drugs · doi:10.1007/s40263-019-00605-7 · Cited by 156
Edinger, K. L., & Frye, C. A. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.11.001 · Cited by 152
Luchetti, S., Huitinga, I., & Swaab, D. F. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.010 · Cited by 164
Chuang, S.-H., & Reddy, D. S. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.244673 · Cited by 149
Anxiolytic activity of progesterone in progesterone receptor knockout mice
Reddy, D. S., O’Malley, B. W., & Rogawski, M. A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.002 · Cited by 148
The neuroendocrine control of the circadian system: Adolescent chronotype
Hagenauer, M. H., & Lee, T. M. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.04.003 · Cited by 143
Fox, H. C., Sofuoglu, M., MORGAN, P. T., Tuit, K. L., & Sinha, R. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.12.022 · Cited by 147
Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?
Schüle, C., Eser, D., Baghai, T. C., Nothdurfter, C., Kessler, J. S., & Rupprecht, R. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.025 · Cited by 146
Self-citationJoffe, H., de Wit, A. E., Coborn, J. E., Crawford, S., Freeman, M. P., Wiley, A., Athappilly, G. K., Kim, S., Sullivan, K. A., Cohen, L. S., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz181 · Cited by 137
Aspects of the homeostaic plasticity of GABAA receptor‐mediated inhibition
Módy, I. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.077362 · Cited by 135
Meffre, D., Labombarda, F., Delespierre, B., Chastre, A., Nicola, A. F. D., Stein, D. G., Schumacher, M., & Guennoun, R. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.11.039 · Cited by 132
Verleye, M., Akwa, Y., Lière, P., Ladurelle, N., Pianos, A., Eychenne, B., Schumacher, M., & Gillardin, J. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.11.013 · Cited by 148
Naert, G., Maurice, T., Tapia‐Arancibia, L., & Givalois, L. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.09.002 · Cited by 131
Dysfunctional stress responses in chronic pain
Woda, A., Picard, P., & Dutheil, F. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.05.017 · Cited by 128
Pathogenesis and Treatment of Pruritus in Cholestasis
Kremer, A. E., Beuers, U. H., Elferink, R. P. J. O., & Pusl, T. (2008) · Drugs · doi:10.2165/00003495-200868150-00006 · Cited by 127
Brunton, P. J., McKay, A. J., Ochędalski, T., Piastowska, A., Rębas, E., Lachowicz, A., & Russell, J. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0708-09.2009 · Cited by 126
SCHÜSSLER, P., Kluge, M., Yassouridis, A., Dresler, M., Held, K., Zihl, J., & Steiger, A. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.05.013 · Cited by 120
Increased Glutamate Levels in the Medial Prefrontal Cortex in Patients with Postpartum Depression
McEwen, A. M., Burgess, D., Hanstock, C. C., Seres, P., Khalili, P., Newman, S. C., Baker, G. B., Mitchell, N., Khudabux, J., Allen, P. S., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.101 · Cited by 118
Hausmann, M. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23857 · Cited by 125
Molecular pharmacology of the glycine receptor chloride channel.
Webb, T., & Lynch, J. (2007) · Current pharmaceutical design · doi:10.2174/138161207781368693 · Cited by 119
Puberty, hormones, and sex differences in alcohol abuse and dependence
Witt, E. D. (2006) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2006.10.013 · Cited by 116
Endocrine disturbances in depression
Tichomirowa, M. A., Keck, M. E., Schneider, H. J., Páez-Pereda, M., Renner, U., Holsboer, F., & Stalla, G. K. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345535 · Cited by 111
Neurosteroids and GABAA Receptor Interactions: A Focus on Stress
Gunn, B. G., Brown, A. R., Lambert, J. J., & Belelli, D. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00131 · Cited by 112
Neurosteroids and potential therapeutics: Focus on pregnenolone
Vallée, M. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.09.030 · Cited by 108
Relevance of endogenous 3α-reduced neurosteroids to depression and antidepressant action
Uzunova, V., Sampson, L., & Uzunov, D. P. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0201-6 · Cited by 109
Neuroactive steroids, neurosteroidogenesis and sex
Giatti, S., García‐Segura, L. M., Barreto, G. E., & Melcangi, R. C. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.06.007 · Cited by 107
Peripheral nerves: a target for the action of neuroactive steroids
Melcangi, R. C., Cavarretta, I. T. R., Ballabio, M., Leonelli, E., Schenone, A. E., Azcoitia, Í., García‐Segura, L. M., & Magnaghi, V. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.021 · Cited by 105
Endogenous and synthetic neurosteroids in treatment of Niemann–Pick Type C disease
Mellon, S. H., Gong, W., & Schonemann, M. D. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.05.012 · Cited by 102
Lagunas, N., Calmarza-Font, I., Diz-Chaves, Y., & García‐Segura, L. M. (2010) · Hormones and Behavior · doi:10.1016/j.yhbeh.2010.07.014 · Cited by 104
Pathophysiology of Hepatic Encephalopathy: A New Look at GABA from the Molecular Standpoint
Ahboucha, S., & Butterworth, R. F. (2004) · Metabolic Brain Disease · doi:10.1023/b:mebr.0000043979.58915.41 · Cited by 99
Tolerance to allopregnanolone with focus on the GABA‐A receptor
Türkmen, Ş., Bäckström, T. C., Wahlström, G., Andréen, L., & Johansson, I. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01059.x · Cited by 102
Hormones, nicotine, and cocaine: Clinical studies
Mello, N. K. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.10.003 · Cited by 96
Gamma-hydroxybutyrate – a drug of abuse
Drasbek, K. R., Christensen, J., & Jensen, K. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00712.x · Cited by 96
Young, E. A., Kornstein, S. G., Harvey, A. T., Wisniewski, S. R., Barkin, J. L., D, M. F. M., Trivedi, M. H., & Rush, A. J. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.05.013 · Cited by 94
Progesterone: The neglected hormone in schizophrenia? A focus on progesterone-dopamine interactions
Sun, J., Walker, A. J., Dean, B., van den Buuse, M., & Gogos, A. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.08.019 · Cited by 92
Neurosteroids, neuroactive steroids, and symptoms of affective disorders
Dubrovsky, B. O. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.06.016 · Cited by 88
Zwanzger, P., & Rupprecht, R. (2005) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0525 · Cited by 87
Self-citationSex Hormones and Pain in Regularly Menstruating Women With Fibromyalgia Syndrome
Okifuji, A., & Turk, D. C. (2006) · Journal of Pain · doi:10.1016/j.jpain.2006.04.005 · Cited by 86
Sze, Y., & Brunton, P. J. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14615 · Cited by 85
Jordan, K., Fromberger, P., Stolpmann, G., & Müller, J. L. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02393.x · Cited by 84
Rapkin, A. J., Morgan, M. L., Sogliano, C., Biggio, G., & Concas, A. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.10.031 · Cited by 83
Development of the selective progesterone receptor modulator CDB-2914 for clinical indications
Blithe, D., Nieman, L. K., Blye, R. P., Stratton, P., & Passaro, M. (2003) · Steroids · doi:10.1016/s0039-128x(03)00118-1 · Cited by 82
A Peroxygenase from Chaetomium globosum Catalyzes the Selective Oxygenation of Testosterone
Kiebist, J., Schmidtke, K., Zimmermann, J., Kellner, H., Jehmlich, N., Ullrich, R., Zänder, D., Hofrichter, M., & Scheibner, K. (2017) · ChemBioChem · doi:10.1002/cbic.201600677 · Cited by 81
Galimberti, C. A., Magri, F., Copello, F., Arbasino, C., Cravello, L., Casu, M., Patrone, V., & Murialdo, G. (2005) · Epilepsia · doi:10.1111/j.0013-9580.2005.59704.x · Cited by 78
Engin, E., & Treit, D. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282d28f6f · Cited by 83
Neurobiology of DHEA and effects on sexuality, mood and cognition
Pluchino, N., Drakopoulos, P., Bianchi‐Demicheli, F., Wenger, J. M., Petignat, P., & Genazzani, A. R. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.04.012 · Cited by 80
Veiga, S. J., Melcangi, R. C., DonCarlos, L. L., García‐Segura, L. M., & Azcoitia, Í. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.05.008 · Cited by 75
Novel Pharmacological Approaches to the Treatment of Depression
Elias, E., Zhang, A. Y., & Manners, M. T. (2022) · Life · doi:10.3390/life12020196 · Cited by 77
Neuronal Control of Breathing: Sex and Stress Hormones
Behan, M., & Kinkead, R. (2011) · Comprehensive physiology · doi:10.1002/cphy.c100027 · Cited by 75
Protective actions of ovarian hormones in the serotonin system of macaques
Bethea, C. L., Reddy, A. P., Tokuyama, Y., Henderson, J. A., & Lima, F. B. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.003 · Cited by 73
Cutler, S. M., Pettus, E. H., Hoffman, S. W., & Stein, D. G. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.06.003 · Cited by 73
Jordan, K., Fromberger, P., Stolpmann, G., & Müller, J. L. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02394.x · Cited by 72
Nothdurfter, C., Rammes, G., Baghai, T. C., Schüle, C., Schumacher, M., Papadopoulos, V., & Rupprecht, R. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02166.x · Cited by 74
Self-citationSchüle, C., Romeo, E., Uzunov, D. P., Eser, D., di Michele, F., Baghai, T. C., Pasini, A., Schwarz, M., Kempter, H., & Rupprecht, R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001782 · Cited by 73
Self-citationNeurosteroids and GABAergic signaling in health and disease
MacKenzie, G., & Maguire, J. L. (2012) · BioMolecular Concepts · doi:10.1515/bmc-2012-0033 · Cited by 71
Experimental anxiety in the black and white model in cycling, pregnant and lactating rats
Zuluaga, M. J., Agrati, D., Pereira, M., Uriarte, N., Fernández‐Guasti, A., & Ferreira, A. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.12.004 · Cited by 69
Neuroactive steroids and affective disorders
Eser, D., Schüle, C., Baghai, T. C., Romeo, E., Uzunov, D. P., & Rupprecht, R. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.05.020 · Cited by 69
Self-citationFrye, C. A., Sumida, K., Dudek, B. C., Harney, J. P., Lydon, J. P., O’Malley, B. W., Pfaff, D. W., & Rhodes, M. E. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0309-3 · Cited by 66
Effects of the antidepressant mianserin in zebrafish: Molecular markers of endocrine disruption
van der Ven, K., Keil, D., Moens, L., Hummelen, P. V., van Remortel, P., Maras, M., & Coen, W. D. (2006) · Chemosphere · doi:10.1016/j.chemosphere.2006.03.079 · Cited by 72
The Bull of Wall Street: Experimental Analysis of Testosterone and Asset Trading
Nadler, A., Jiao, P., Johnson, C. J., Alexander, V., & Zak, P. J. (2017) · Management Science · doi:10.1287/mnsc.2017.2836 · Cited by 65
Animal models of post-traumatic stress disorder and novel treatment targets
Aspesi, D., & Pinna, G. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000467 · Cited by 67
Rupprecht, R., Wetzel, C. H., Dorostkar, M. M., Herms, J. W., Albert, N. L., Schwarzbach, J. V., Schumacher, M., & Neumann, I. D. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01561-3 · Cited by 66
Self-citationTestosterone and Sleep-Related Erections: An Overview*
Montorsi, F., & Oettel, M. (2005) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2005.00095.x · Cited by 61
Alcohol Effects on Stress Pathways
Blaine, S. K., Milivojevic, V., Fox, H. C., & Sinha, R. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716632512 · Cited by 68
The Relevance of Neuroactive Steroids in Schizophrenia, Depression, and Anxiety Disorders
MacKenzie, E. M., Odontiadis, J., Mellédo, J. L., Prior, T. I., & Baker, G. B. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9086-0 · Cited by 61
Metadata
- Authors
- Rupprecht, R.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Corresponding author
- Rupprecht, R.
- ORCID
- Rupprecht, R.
- Venue
- Psychoneuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2003-02
- Volume
- 28
- Issue
- 2
- Pages
- 139-168
- ISSN
- 0306-4530 (ISSN-L)
- OpenAlex
- W2047844288
- Cited by
- 427
- References
- 151
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 12 · 2023: 14 · 2022: 13 · 2021: 6 · 2020: 11 · 2019: 14 · 2018: 13 · 2017: 6 · 2016: 13 · 2015: 18 · 2014: 14 · 2013: 18 · 2012: 26
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychoneuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- neurosteroids, progesterone, deoxycorticosterone, GABA-A receptor modulation, 5-HT3 receptor antagonism, glutamate receptors, non-genomic steroid action, steroid hormone receptors, locomotor activity, sleep EEG, depression, anxiety, ethanol withdrawal, panic disorder, antidepressants, mental illness
- MeSH terms
- Anesthesia, Animals, Anticonvulsants, Antidepressive Agents, Humans, Nervous System, Receptors, GABA-A, Receptors, Serotonin, Sleep, Steroids, Antipsychotic Agents, Anti-Anxiety Agents, Gene Expression, Receptors, Neurotransmitter
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review